Application of regorafenib to metastatic colorectal cancer patients in clinical practice; a retrospective study

被引：0
|
作者：
Kawai, Sadayuki [1 ]
Sakamoto, Yasuhiro [1 ]
Takahashi, Yoshikazu [1 ]
Ichikawa, Sonoko [1 ]
Gamoh, Makio [1 ]
机构：
[1] Osaki Citizen Hosp, Dept Med Oncol, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-5-9
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [31] Regorafenib in the treatment of metastatic colorectal cancer
    de la Fouchardiere, Christelle
    FUTURE ONCOLOGY, 2018, 14 (22) : 2239 - 2246
  • [32] Regorafenib: A Review in Metastatic Colorectal Cancer
    Sohita Dhillon
    Drugs, 2018, 78 : 1133 - 1144
  • [33] Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study
    Zhou, Hong
    Wang, Yuehui
    Lin, Yanfang
    Cai, Wenjie
    Li, Xiaofeng
    He, Xiaomeng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [34] Regorafenib and trifluridine/tipiracil efficacy and safety in chemorefractory metastatic colorectal cancer patients: A single Bulgarian centre retrospective study
    Penkova, M.
    Stoyanov, D.
    Panayotova, T.
    Donev, I.
    Petrova, M.
    Conev, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S100 - S100
  • [35] The role of regorafenib in metastatic colorectal cancer
    Riechelmann, Rachel
    Grothey, Axel
    LANCET ONCOLOGY, 2015, 16 (06): : 596 - 597
  • [36] Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A single institution retrospective study
    Patel, Anuj K.
    Ng, Kimmie
    Duh, Mei Sheng
    Barghout, Victoria E.
    Lynn Huynh
    Yenikomshian, Mihran Ara
    Sharperson, Camara
    Brais, Lauren K.
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [37] Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study
    Yekeduz, Emre
    Ozbay, Mehmet Fatih
    Caglayan, Dilek
    Yildirim, Atila
    Erol, Cihan
    Yildirim, Hasan Cagri
    Tunc, Sezai
    Ozyurt, Neslihan
    Ozdemir, Feyyaz
    Sendur, Mehmet Ali Nahit
    Isikdogan, Abdurrahman
    Kilickap, Saadettin
    Urun, Yuksel
    Yalcin, Suayib
    Artac, Mehmet
    Coskun, Hasan Senol
    Utkan, Gungor
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 1973 - 1979
  • [38] Regorafenib approved in Metastatic Colorectal cancer
    Andre, Thierry
    Dumont, Sarah N.
    BULLETIN DU CANCER, 2013, 100 (10) : 1027 - 1029
  • [39] Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study
    Yekeduz, Emre
    Ozbay, Mehmet Fatih
    Caglayan, Dilek
    Yildirim, Atila
    Erol, Cihan
    Yildirim, Hasan Cagri
    Tunc, Sezai
    Ozyurt, Neslihan
    Ozdemir, Feyyaz
    Sendur, Mehmet Ali Nahit
    Isikdogan, Abdurrahman
    Kilickap, Saadettin
    Urun, Yuksel
    Yalcin, Suayib
    Artac, Mehmet
    Coskun, Hasan Senol
    Utkan, Gungor
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [40] Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study
    Emre Yekedüz
    Mehmet Fatih Özbay
    Dilek Çağlayan
    Atila Yıldırım
    Cihan Erol
    Hasan Çağrı Yıldırım
    Sezai Tunç
    Neslihan Özyurt
    Feyyaz Özdemir
    Mehmet Ali Nahit Şendur
    Abdurrahman Işıkdoğan
    Saadettin Kılıçkap
    Yüksel Ürün
    Şuayib Yalçın
    Mehmet Artaç
    Hasan Şenol Coşkun
    Güngör Utkan
    European Journal of Clinical Pharmacology, 2022, 78 : 1973 - 1979
12345